Document is current
Any future updates will be listed below
-
Authors
Tarancon-Diez, Laura
Iriarte-Gahete, Marianela
Sanchez-Mingo, Pilar
Muñoz-Fernandez, Mª Ángeles
Navarro-Gomez, Maria Luisa
Pacheco, Yolanda M.
Leal, Manuel
-
Funding
Funding for this research was provided by:
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain (CB21/13/00077, CB21/13/00077)
Instituto de Salud Carlos III (ISCIII) through the Miguel Servet Program, Madrid, Spain (CP23/00009)
Instituto de Salud Carlos III (ISCIII) through the Río Hortega Program, Madrid, Spain (CM22/00198)
Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBERBBN), Madrid, Spain (CB22/01/00041)
Fondo de Investigación Sanitaria, Instituto de Salud Carlos III (ISCIII), Madrid, Spain (PI21/00357)
- License Information
-
More Information
Article History
Received: 2 July 2024
Accepted: 24 December 2024
First Online: 8 January 2025
Declarations
:
: The authors declare no competing interests.
: The study was approved by the ethic committee of Hospital Universitario La Paz in Madrid (PI-4636). Written informed consent was obtained from all HIV participants before inclusion in CoRISpe-FARO and from all HD before inclusion in the study.
